 | • レポートコード：QYR2104Z5822 • 出版社/出版日：QYResearch / 2021年4月10日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ウラピジルのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、錠剤）、用途別市場規模（重症高血圧症及び難治性高血圧症、周術期高血圧症管理、本態性高血圧症、腎性高血圧症、褐色細胞腫高血圧、うっ血性心不全、排尿障害、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ウラピジルの市場動向 ・企業の競争状況、市場シェア ・ウラピジルの種類別市場規模（注射、錠剤） ・ウラピジルの用途別市場規模（重症高血圧症及び難治性高血圧症、周術期高血圧症管理、本態性高血圧症、腎性高血圧症、褐色細胞腫高血圧、うっ血性心不全、排尿障害、その他） ・ウラピジルの北米市場規模2016-2027（アメリカ、カナダ） ・ウラピジルのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ウラピジルのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ウラピジルの中南米市場規模2016-2027（メキシコ、ブラジル） ・ウラピジルの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Takeda、Sanwa Kagaku Kenkyusho、AbbVie、Kaken Pharm、Abbott、Huayu (Wuxi) Pharmaceutical、Shandong Luoxin Pharmaceutical Group、Guangzhou Wanzheng Pharmaceutical、Hebei Yipin Pharmaceutical、Xi'an Lijun Pharmaceutical、Tonghua Jinma Pharmaceutical Group、Changchun Tiancheng Pharmaceutical、Heilongjiang Fuhe Pharmaceutical Group） ・結論 |
Market Analysis and Insights: Global Urapidil Market
The global Urapidil market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Urapidil market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Urapidil market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Urapidil market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Urapidil market.
Global Urapidil Scope and Market Size
Urapidil market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Urapidil market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Injection
Tablets
Segment by Application
Severe Hypertension And Refractory Hypertension
Control Perioperative Hypertension
Essential Hypertension
Renal Hypertension
High Blood Pressure Caused By Pheochromocytoma
Congestive Heart Failure
Dysuria
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Takeda
Sanwa Kagaku Kenkyusho
AbbVie
Kaken Pharm
Abbott
Huayu (Wuxi) Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Guangzhou Wanzheng Pharmaceutical
Hebei Yipin Pharmaceutical
Xi’an Lijun Pharmaceutical
Tonghua Jinma Pharmaceutical Group
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Urapidil Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Tablets
1.3 Market by Application
1.3.1 Global Urapidil Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Severe Hypertension And Refractory Hypertension
1.3.3 Control Perioperative Hypertension
1.3.4 Essential Hypertension
1.3.5 Renal Hypertension
1.3.6 High Blood Pressure Caused By Pheochromocytoma
1.3.7 Congestive Heart Failure
1.3.8 Dysuria
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Urapidil Market Perspective (2016-2027)
2.2 Urapidil Growth Trends by Regions
2.2.1 Urapidil Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Urapidil Historic Market Share by Regions (2016-2021)
2.2.3 Urapidil Forecasted Market Size by Regions (2022-2027)
2.3 Urapidil Industry Dynamic
2.3.1 Urapidil Market Trends
2.3.2 Urapidil Market Drivers
2.3.3 Urapidil Market Challenges
2.3.4 Urapidil Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Urapidil Players by Revenue
3.1.1 Global Top Urapidil Players by Revenue (2016-2021)
3.1.2 Global Urapidil Revenue Market Share by Players (2016-2021)
3.2 Global Urapidil Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Urapidil Revenue
3.4 Global Urapidil Market Concentration Ratio
3.4.1 Global Urapidil Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urapidil Revenue in 2020
3.5 Urapidil Key Players Head office and Area Served
3.6 Key Players Urapidil Product Solution and Service
3.7 Date of Enter into Urapidil Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Urapidil Breakdown Data by Type
4.1 Global Urapidil Historic Market Size by Type (2016-2021)
4.2 Global Urapidil Forecasted Market Size by Type (2022-2027)
5 Urapidil Breakdown Data by Application
5.1 Global Urapidil Historic Market Size by Application (2016-2021)
5.2 Global Urapidil Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Urapidil Market Size (2016-2027)
6.2 North America Urapidil Market Size by Type
6.2.1 North America Urapidil Market Size by Type (2016-2021)
6.2.2 North America Urapidil Market Size by Type (2022-2027)
6.2.3 North America Urapidil Market Size by Type (2016-2027)
6.3 North America Urapidil Market Size by Application
6.3.1 North America Urapidil Market Size by Application (2016-2021)
6.3.2 North America Urapidil Market Size by Application (2022-2027)
6.3.3 North America Urapidil Market Size by Application (2016-2027)
6.4 North America Urapidil Market Size by Country
6.4.1 North America Urapidil Market Size by Country (2016-2021)
6.4.2 North America Urapidil Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Urapidil Market Size (2016-2027)
7.2 Europe Urapidil Market Size by Type
7.2.1 Europe Urapidil Market Size by Type (2016-2021)
7.2.2 Europe Urapidil Market Size by Type (2022-2027)
7.2.3 Europe Urapidil Market Size by Type (2016-2027)
7.3 Europe Urapidil Market Size by Application
7.3.1 Europe Urapidil Market Size by Application (2016-2021)
7.3.2 Europe Urapidil Market Size by Application (2022-2027)
7.3.3 Europe Urapidil Market Size by Application (2016-2027)
7.4 Europe Urapidil Market Size by Country
7.4.1 Europe Urapidil Market Size by Country (2016-2021)
7.4.2 Europe Urapidil Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Urapidil Market Size (2016-2027)
8.2 Asia-Pacific Urapidil Market Size by Type
8.2.1 Asia-Pacific Urapidil Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Urapidil Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Urapidil Market Size by Type (2016-2027)
8.3 Asia-Pacific Urapidil Market Size by Application
8.3.1 Asia-Pacific Urapidil Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Urapidil Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Urapidil Market Size by Application (2016-2027)
8.4 Asia-Pacific Urapidil Market Size by Region
8.4.1 Asia-Pacific Urapidil Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Urapidil Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Urapidil Market Size (2016-2027)
9.2 Latin America Urapidil Market Size by Type
9.2.1 Latin America Urapidil Market Size by Type (2016-2021)
9.2.2 Latin America Urapidil Market Size by Type (2022-2027)
9.2.3 Latin America Urapidil Market Size by Type (2016-2027)
9.3 Latin America Urapidil Market Size by Application
9.3.1 Latin America Urapidil Market Size by Application (2016-2021)
9.3.2 Latin America Urapidil Market Size by Application (2022-2027)
9.3.3 Latin America Urapidil Market Size by Application (2016-2027)
9.4 Latin America Urapidil Market Size by Country
9.4.1 Latin America Urapidil Market Size by Country (2016-2021)
9.4.2 Latin America Urapidil Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Urapidil Market Size (2016-2027)
10.2 Middle East & Africa Urapidil Market Size by Type
10.2.1 Middle East & Africa Urapidil Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Urapidil Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Urapidil Market Size by Type (2016-2027)
10.3 Middle East & Africa Urapidil Market Size by Application
10.3.1 Middle East & Africa Urapidil Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Urapidil Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Urapidil Market Size by Application (2016-2027)
10.4 Middle East & Africa Urapidil Market Size by Country
10.4.1 Middle East & Africa Urapidil Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Urapidil Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Urapidil Introduction
11.1.4 Takeda Revenue in Urapidil Business (2016-2021)
11.1.5 Takeda Recent Development
11.2 Sanwa Kagaku Kenkyusho
11.2.1 Sanwa Kagaku Kenkyusho Company Details
11.2.2 Sanwa Kagaku Kenkyusho Business Overview
11.2.3 Sanwa Kagaku Kenkyusho Urapidil Introduction
11.2.4 Sanwa Kagaku Kenkyusho Revenue in Urapidil Business (2016-2021)
11.2.5 Sanwa Kagaku Kenkyusho Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Urapidil Introduction
11.3.4 AbbVie Revenue in Urapidil Business (2016-2021)
11.3.5 AbbVie Recent Development
11.4 Kaken Pharm
11.4.1 Kaken Pharm Company Details
11.4.2 Kaken Pharm Business Overview
11.4.3 Kaken Pharm Urapidil Introduction
11.4.4 Kaken Pharm Revenue in Urapidil Business (2016-2021)
11.4.5 Kaken Pharm Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Urapidil Introduction
11.5.4 Abbott Revenue in Urapidil Business (2016-2021)
11.5.5 Abbott Recent Development
11.6 Huayu (Wuxi) Pharmaceutical
11.6.1 Huayu (Wuxi) Pharmaceutical Company Details
11.6.2 Huayu (Wuxi) Pharmaceutical Business Overview
11.6.3 Huayu (Wuxi) Pharmaceutical Urapidil Introduction
11.6.4 Huayu (Wuxi) Pharmaceutical Revenue in Urapidil Business (2016-2021)
11.6.5 Huayu (Wuxi) Pharmaceutical Recent Development
11.7 Shandong Luoxin Pharmaceutical Group
11.7.1 Shandong Luoxin Pharmaceutical Group Company Details
11.7.2 Shandong Luoxin Pharmaceutical Group Business Overview
11.7.3 Shandong Luoxin Pharmaceutical Group Urapidil Introduction
11.7.4 Shandong Luoxin Pharmaceutical Group Revenue in Urapidil Business (2016-2021)
11.7.5 Shandong Luoxin Pharmaceutical Group Recent Development
11.8 Guangzhou Wanzheng Pharmaceutical
11.8.1 Guangzhou Wanzheng Pharmaceutical Company Details
11.8.2 Guangzhou Wanzheng Pharmaceutical Business Overview
11.8.3 Guangzhou Wanzheng Pharmaceutical Urapidil Introduction
11.8.4 Guangzhou Wanzheng Pharmaceutical Revenue in Urapidil Business (2016-2021)
11.8.5 Guangzhou Wanzheng Pharmaceutical Recent Development
11.9 Hebei Yipin Pharmaceutical
11.9.1 Hebei Yipin Pharmaceutical Company Details
11.9.2 Hebei Yipin Pharmaceutical Business Overview
11.9.3 Hebei Yipin Pharmaceutical Urapidil Introduction
11.9.4 Hebei Yipin Pharmaceutical Revenue in Urapidil Business (2016-2021)
11.9.5 Hebei Yipin Pharmaceutical Recent Development
11.10 Xi’an Lijun Pharmaceutical
11.10.1 Xi’an Lijun Pharmaceutical Company Details
11.10.2 Xi’an Lijun Pharmaceutical Business Overview
11.10.3 Xi’an Lijun Pharmaceutical Urapidil Introduction
11.10.4 Xi’an Lijun Pharmaceutical Revenue in Urapidil Business (2016-2021)
11.10.5 Xi’an Lijun Pharmaceutical Recent Development
11.11 Tonghua Jinma Pharmaceutical Group
11.11.1 Tonghua Jinma Pharmaceutical Group Company Details
11.11.2 Tonghua Jinma Pharmaceutical Group Business Overview
11.11.3 Tonghua Jinma Pharmaceutical Group Urapidil Introduction
11.11.4 Tonghua Jinma Pharmaceutical Group Revenue in Urapidil Business (2016-2021)
11.11.5 Tonghua Jinma Pharmaceutical Group Recent Development
11.12 Changchun Tiancheng Pharmaceutical
11.12.1 Changchun Tiancheng Pharmaceutical Company Details
11.12.2 Changchun Tiancheng Pharmaceutical Business Overview
11.12.3 Changchun Tiancheng Pharmaceutical Urapidil Introduction
11.12.4 Changchun Tiancheng Pharmaceutical Revenue in Urapidil Business (2016-2021)
11.12.5 Changchun Tiancheng Pharmaceutical Recent Development
11.13 Heilongjiang Fuhe Pharmaceutical Group
11.13.1 Heilongjiang Fuhe Pharmaceutical Group Company Details
11.13.2 Heilongjiang Fuhe Pharmaceutical Group Business Overview
11.13.3 Heilongjiang Fuhe Pharmaceutical Group Urapidil Introduction
11.13.4 Heilongjiang Fuhe Pharmaceutical Group Revenue in Urapidil Business (2016-2021)
11.13.5 Heilongjiang Fuhe Pharmaceutical Group Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Urapidil Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injection
Table 3. Key Players of Tablets
Table 4. Global Urapidil Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Urapidil Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Urapidil Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Urapidil Market Share by Regions (2016-2021)
Table 8. Global Urapidil Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Urapidil Market Share by Regions (2022-2027)
Table 10. Urapidil Market Trends
Table 11. Urapidil Market Drivers
Table 12. Urapidil Market Challenges
Table 13. Urapidil Market Restraints
Table 14. Global Urapidil Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Urapidil Market Share by Players (2016-2021)
Table 16. Global Top Urapidil Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urapidil as of 2020)
Table 17. Ranking of Global Top Urapidil Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Urapidil Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Urapidil Product Solution and Service
Table 21. Date of Enter into Urapidil Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Urapidil Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Urapidil Revenue Market Share by Type (2016-2021)
Table 25. Global Urapidil Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Urapidil Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Urapidil Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Urapidil Revenue Market Share by Application (2016-2021)
Table 29. Global Urapidil Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Urapidil Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Urapidil Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Urapidil Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Urapidil Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Urapidil Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Urapidil Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Urapidil Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Urapidil Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Urapidil Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Urapidil Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Urapidil Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Urapidil Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Urapidil Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Urapidil Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Urapidil Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Urapidil Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Urapidil Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Urapidil Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Urapidil Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Urapidil Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Urapidil Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Urapidil Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Urapidil Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Urapidil Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Urapidil Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Urapidil Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Urapidil Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Urapidil Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Urapidil Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Urapidil Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Urapidil Market Size by Country (2022-2027) & (US$ Million)
Table 61. Takeda Company Details
Table 62. Takeda Business Overview
Table 63. Takeda Urapidil Product
Table 64. Takeda Revenue in Urapidil Business (2016-2021) & (US$ Million)
Table 65. Takeda Recent Development
Table 66. Sanwa Kagaku Kenkyusho Company Details
Table 67. Sanwa Kagaku Kenkyusho Business Overview
Table 68. Sanwa Kagaku Kenkyusho Urapidil Product
Table 69. Sanwa Kagaku Kenkyusho Revenue in Urapidil Business (2016-2021) & (US$ Million)
Table 70. Sanwa Kagaku Kenkyusho Recent Development
Table 71. AbbVie Company Details
Table 72. AbbVie Business Overview
Table 73. AbbVie Urapidil Product
Table 74. AbbVie Revenue in Urapidil Business (2016-2021) & (US$ Million)
Table 75. AbbVie Recent Development
Table 76. Kaken Pharm Company Details
Table 77. Kaken Pharm Business Overview
Table 78. Kaken Pharm Urapidil Product
Table 79. Kaken Pharm Revenue in Urapidil Business (2016-2021) & (US$ Million)
Table 80. Kaken Pharm Recent Development
Table 81. Abbott Company Details
Table 82. Abbott Business Overview
Table 83. Abbott Urapidil Product
Table 84. Abbott Revenue in Urapidil Business (2016-2021) & (US$ Million)
Table 85. Abbott Recent Development
Table 86. Huayu (Wuxi) Pharmaceutical Company Details
Table 87. Huayu (Wuxi) Pharmaceutical Business Overview
Table 88. Huayu (Wuxi) Pharmaceutical Urapidil Product
Table 89. Huayu (Wuxi) Pharmaceutical Revenue in Urapidil Business (2016-2021) & (US$ Million)
Table 90. Huayu (Wuxi) Pharmaceutical Recent Development
Table 91. Shandong Luoxin Pharmaceutical Group Company Details
Table 92. Shandong Luoxin Pharmaceutical Group Business Overview
Table 93. Shandong Luoxin Pharmaceutical Group Urapidil Product
Table 94. Shandong Luoxin Pharmaceutical Group Revenue in Urapidil Business (2016-2021) & (US$ Million)
Table 95. Shandong Luoxin Pharmaceutical Group Recent Development
Table 96. Guangzhou Wanzheng Pharmaceutical Company Details
Table 97. Guangzhou Wanzheng Pharmaceutical Business Overview
Table 98. Guangzhou Wanzheng Pharmaceutical Revenue in Urapidil Business (2016-2021) & (US$ Million)
Table 99. Guangzhou Wanzheng Pharmaceutical Recent Development
Table 100. Hebei Yipin Pharmaceutical Company Details
Table 101. Hebei Yipin Pharmaceutical Business Overview
Table 102. Hebei Yipin Pharmaceutical Urapidil Product
Table 103. Hebei Yipin Pharmaceutical Revenue in Urapidil Business (2016-2021) & (US$ Million)
Table 104. Hebei Yipin Pharmaceutical Recent Development
Table 105. Xi'an Lijun Pharmaceutical Company Details
Table 106. Xi'an Lijun Pharmaceutical Business Overview
Table 107. Xi'an Lijun Pharmaceutical Urapidil Product
Table 108. Xi'an Lijun Pharmaceutical Revenue in Urapidil Business (2016-2021) & (US$ Million)
Table 109. Xi'an Lijun Pharmaceutical Recent Development
Table 110. Tonghua Jinma Pharmaceutical Group Company Details
Table 111. Tonghua Jinma Pharmaceutical Group Business Overview
Table 112. Tonghua Jinma Pharmaceutical Group Urapidil Product
Table 113. Tonghua Jinma Pharmaceutical Group Revenue in Urapidil Business (2016-2021) & (US$ Million)
Table 114. Tonghua Jinma Pharmaceutical Group Recent Development
Table 115. Changchun Tiancheng Pharmaceutical Company Details
Table 116. Changchun Tiancheng Pharmaceutical Business Overview
Table 117. Changchun Tiancheng Pharmaceutical Urapidil Product
Table 118. Changchun Tiancheng Pharmaceutical Revenue in Urapidil Business (2016-2021) & (US$ Million)
Table 119. Changchun Tiancheng Pharmaceutical Recent Development
Table 120. Heilongjiang Fuhe Pharmaceutical Group Company Details
Table 121. Heilongjiang Fuhe Pharmaceutical Group Business Overview
Table 122. Heilongjiang Fuhe Pharmaceutical Group Urapidil Product
Table 123. Heilongjiang Fuhe Pharmaceutical Group Revenue in Urapidil Business (2016-2021) & (US$ Million)
Table 124. Heilongjiang Fuhe Pharmaceutical Group Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Urapidil Market Share by Type: 2020 VS 2027
Figure 2. Injection Features
Figure 3. Tablets Features
Figure 4. Global Urapidil Market Share by Application: 2020 VS 2027
Figure 5. Severe Hypertension And Refractory Hypertension Case Studies
Figure 6. Control Perioperative Hypertension Case Studies
Figure 7. Essential Hypertension Case Studies
Figure 8. Renal Hypertension Case Studies
Figure 9. High Blood Pressure Caused By Pheochromocytoma Case Studies
Figure 10. Congestive Heart Failure Case Studies
Figure 11. Dysuria Case Studies
Figure 12. Other Case Studies
Figure 13. Urapidil Report Years Considered
Figure 14. Global Urapidil Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Urapidil Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Urapidil Market Share by Regions: 2020 VS 2027
Figure 17. Global Urapidil Market Share by Regions (2022-2027)
Figure 18. Global Urapidil Market Share by Players in 2020
Figure 19. Global Top Urapidil Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urapidil as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Urapidil Revenue in 2020
Figure 21. Global Urapidil Revenue Market Share by Type (2016-2021)
Figure 22. Global Urapidil Revenue Market Share by Type (2022-2027)
Figure 23. North America Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Urapidil Market Share by Type (2016-2027)
Figure 25. North America Urapidil Market Share by Application (2016-2027)
Figure 26. North America Urapidil Market Share by Country (2016-2027)
Figure 27. United States Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Urapidil Market Share by Type (2016-2027)
Figure 31. Europe Urapidil Market Share by Application (2016-2027)
Figure 32. Europe Urapidil Market Share by Country (2016-2027)
Figure 33. Germany Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Urapidil Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Urapidil Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Urapidil Market Share by Region (2016-2027)
Figure 43. China Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Urapidil Market Share by Type (2016-2027)
Figure 51. Latin America Urapidil Market Share by Application (2016-2027)
Figure 52. Latin America Urapidil Market Share by Country (2016-2027)
Figure 53. Mexico Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Urapidil Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Urapidil Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Urapidil Market Share by Country (2016-2027)
Figure 59. Turkey Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Urapidil Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Takeda Revenue Growth Rate in Urapidil Business (2016-2021)
Figure 63. Sanwa Kagaku Kenkyusho Revenue Growth Rate in Urapidil Business (2016-2021)
Figure 64. AbbVie Revenue Growth Rate in Urapidil Business (2016-2021)
Figure 65. Kaken Pharm Revenue Growth Rate in Urapidil Business (2016-2021)
Figure 66. Abbott Revenue Growth Rate in Urapidil Business (2016-2021)
Figure 67. Huayu (Wuxi) Pharmaceutical Revenue Growth Rate in Urapidil Business (2016-2021)
Figure 68. Shandong Luoxin Pharmaceutical Group Revenue Growth Rate in Urapidil Business (2016-2021)
Figure 69. Guangzhou Wanzheng Pharmaceutical Revenue Growth Rate in Urapidil Business (2016-2021)
Figure 70. Hebei Yipin Pharmaceutical Revenue Growth Rate in Urapidil Business (2016-2021)
Figure 71. Xi'an Lijun Pharmaceutical Revenue Growth Rate in Urapidil Business (2016-2021)
Figure 72. Tonghua Jinma Pharmaceutical Group Revenue Growth Rate in Urapidil Business (2016-2021)
Figure 73. Changchun Tiancheng Pharmaceutical Revenue Growth Rate in Urapidil Business (2016-2021)
Figure 74. Heilongjiang Fuhe Pharmaceutical Group Revenue Growth Rate in Urapidil Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed